Highlander Capital Management’s Novo Nordisk NVO Stock Holding History

Highlander Capital Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$3.22M	Hold	25,100	–	–	1.1%	17
2023 Q4	$2.6M	Buy	25,100 +100	+0.4%	+$9.89K	0.92%	22
2023 Q3	$2.27M	Buy	+25,000	New	+$2.2M	0.89%	22
2017 Q1	–	Sell	-1,500	Closed	-$27K	–	778
2016 Q4	$27K	Sell	1,500 -2,070	-58%	-$37.5K	0.02%	457
2016 Q3	$74K	Hold	3,570	–	–	0.07%	288
2016 Q2	$96K	Hold	3,570	–	–	0.09%	246
2016 Q1	$97K	Sell	3,570 -1,500	-30%	-$40.2K	0.09%	247
2015 Q4	$147K	Hold	5,070	–	–	0.14%	179
2015 Q3	$137K	Hold	5,070	–	–	0.13%	188
2015 Q2	$139K	Hold	5,070	–	–	0.12%	196
2015 Q1	$135K	Hold	5,070	–	–	0.12%	203
2014 Q4	$107K	Hold	5,070	–	–	0.09%	239
2014 Q3	$121K	Hold	5,070	–	–	0.11%	201
2014 Q2	$117K	Hold	5,070	–	–	0.11%	213
2014 Q1	$116K	Hold	5,070	–	–	0.11%	200
2013 Q4	$93.7K	Hold	5,070	–	–	0.09%	240
2013 Q3	$85.8K	Sell	5,070 -5,750	-53%	-$96.7K	0.09%	248
2013 Q2	$168K	Buy	+10,820	New	+$180K	0.18%	147

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Highlander Capital Management's NVO Position: Q1 2024 in Review

Highlander Capital Management held its Novo Nordisk (NVO) position steady in Q1 2024 at 25,100 shares worth $3.22M. The position accounts for 1.1% of the portfolio, ranked #17.

Highlander Capital Management first reported a position in NVO in Q2 2013 and has held it in 18 quarters since. 1,745 funds tracked by Wall St. Rank hold NVO as of Q1 2024.

Highlander Capital Management held 25,100 shares of Novo Nordisk worth $3.22M as of Q1 2024.
Highlander Capital Management left its Novo Nordisk share count unchanged in Q1 2024.
Novo Nordisk made up 1.1% of Highlander Capital Management's portfolio in Q1 2024, its #17 holding.
Highlander Capital Management first reported a position in Novo Nordisk in Q2 2013 and has held it in 18 quarters since.
1,745 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2024.

Based on Highlander Capital Management's 13F filing for Q1 2024, filed 20 May 2024.